三联雾化吸入治疗儿童哮喘急性发作的疗效观察

Observation of the efficacy of treating acute asthma attack in children with triad nebulization

目的 :观察普米克令舒混悬液加博力康尼和爱全乐雾化液三联雾化吸入治疗儿童哮喘急性发作的疗效。方法 :中重度哮喘急性发作患儿60例 ,分3组 ,每组20例。观察组予三联雾化吸入 ;对照分2组 ,一组予静点氟美松加博力康尼和爱全乐雾化液雾化吸入 ;另一组予静点氟美松和氨茶碱。观察用药后患儿症状体征改善情况。结果 :观察组治疗后症状体征改善及病程缩短较两对照组均存在显著性差异 (均P<0.01)。结论 :普米克令舒混悬液加博利康尼和爱全乐雾化液三联雾化吸入治疗儿童哮喘急性发作 ,疗效显著 。

Objective:To observe the efficacy of triad nebulization with budesonide suspenˉsion,terbutaline and atrovent in children with acute asthma attack.Methods:60cases with moderate-to-severe acute asthma attack were divided into three groups,each group includes20cases.Trial group was treated with triad nebulization;controlⅠwith intravenous dexamˉethasone united with nebulized terbutaline and atrovent;and controlⅡwith intravenous dexˉamethasone and aminophyline.To observe the improvement of symptoms and signs after treatˉment.Results:The improvement of symptoms and signs and the shortening of course were sigˉnificant in trial group than in two control groups(P<0.01).Conclusion:Triad nebulization with budesonide suspension,terbutaline and atrovent to treat the acute asthma attack in children has a obvious effect,and we suggest it to be used widely in clinic.